Skip to main content

Table 4 Difference in means between treatment and control groups for TC at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author

Sample size (treatment group vs. control group)

Difference

95% CI

Cabral et al. [57]

32 (14 vs. 18)

− 1.07 mmol/L*

− 2.49 to 0.36

Caraccio et al. [58]

49 (24 vs. 25)

− 0.30 mmol/L*

− 0.92 to 0.32

Duman et al. [60]

39 (20 vs. 19)

0.00 mmol/L*

− 0.98 to 0.98

Iqbal et al. [62]

64 (32 vs. 32)

− 0.10 mmol/L*

− 0.59 to 0.39

Liu et al. [64]

119 (60 vs. 59)

− 0.29 mmol/L**

− 0.54 to − 0.04

Mikhail et al. [66]

120 (60 vs. 60)

− 0.30 mmol/L*

− 0.58 to − 0.30

Monzani et al. [68]

45 (23 vs. 22)

− 1.56 mmol/L*

− 2.91 to − 0.20

Nagasaki et al. [69]

95 (48 vs. 47)

− 0.14 mmol/L**

− 0.54 to 0.26

Teixeira et al. [74, 75]

26 (11 vs. 15)

− 0.32 mmol/L*

− 1.79 to 1.16

  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group